Florbetapir(18F)

氟贝他吡[18F]

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameFlorbetapir(18F)
Drug Alias Name氟[18F]贝他吡Florpiramine F 18氟[18F]洛贝平Florbetapirum (18F)Florbetapir F 18 (USAN) +[11] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsContrast agentsCognitive DysfunctionNeurodegenerative Diseases +[8] 
Global Approved IndicationsContrast agentsAlzheimer Disease
Approved Indications in ChinaContrast agentsAlzheimer Disease
Original Approved Country/TerritoryUnited States
Original Approved Date2012/04/06
Country/TerritoryUnited StatesPuerto RicoUnited Kingdom +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesPDRadiopharma IncUniversidad Central del CaribeBeijing Xinhe Pharmaceutical Technology Co Ltd +[6] 
Inactive CompaniesEli Lilly And CompanyMolecular Neuroimaging LlcInvicro Llc
Active IndicationsContrast agentsAlzheimer DiseaseGlioblastoma
Inactive IndicationsCognitive DysfunctionNeurodegenerative DiseasesFrontotemporal Dementia +[5] 

Other Information

ATC CodeV09AX05
Related LinksWikipediaDrugBankKEGG